Abstracts & Presentations
International Conferences
2009 International Conferences
(By conference, by month, by author)
47th Annual Meeting of the Infectious Diseases Society of America,
Philadelphia, Pennsylvania, October 2009
Baker J, Levels of inflammatory and coagulation markers after starting
antiretroviral therapy --
Abstract |
Poster
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape
Town, South Africa, July 2009
Babiker A, An analysis of pooled data from the ESPRIT and SILCAAT Studies:
Findings by latest CD4+ count --
Abstract |
Slides
Paton N, Association between activation of inflammatory and coagulation
pathways and mortality during long-term follow up in SMART --
Abstract |
Poster
Tavel J, Immunologic and virologic effects of intermittent IL-2 alone or
with peri-cycle antiretroviral therapy (ART): The STALWART Study --
Abstract |
Slides
58th Annual Scientific Session of the American College of Cardiology,
Orlando, Florida, March 2009
Duprez D, Inflammation, coagulation and cardiovascular disease in the
Strategies Management of Antiretroviral Therapy --
Abstract |
Poster
CROI
16th Conference on Retroviruses and Opportunistic Infections, Montreal,
Canada, February 2009
Duprez D, High-density lipoprotein particles but not low-density lipoprotein
particles predict cardiovascular disease events in HIV patients: Strategies for
Management of ART study --
Abstract |
Slides
Losso M, Effect of interleukin-2 on clinical outcomes in patients with a CD4+
cell count of 300/mm3: Primary results of the ESPRIT study --
Abstract |
Slides
Neuhaus J, Markers of inflammation, coagulation, and renal function in
HIV-infected adults in the Strategies for Management of ART study and in 2 large
population-based studies, Coronary Artery Risk Development in Young Adults and
Multi-Ethnic Study of Atherosclerosis --
Abstract |
Poster
Peters L, Interruption of ART and changes in hyaluronic acid as marker of
liver fibrosis progression in strategies for management of ART viral
hepatitis-co-infected participants and matched controls --
Abstract |
Poster
Rockstroh J, Does treatment interruption within the Strategies for the
Management of ART trial lead to changes in HCV Load in HIV/HCV-co-infected i
patients? --
Abstract |
Poster
Rodger A, Does activation of inflammatory and coagulation pathways
independently predict the development of opportunistic disease in patients
with HIV infection ? --
Abstract |
Poster
Soriano V, ART reinitiation and HBV rebound among HIV/HBV-co-infected patients
following ART interruption in the Strategies for the Management of ART Study
--
Abstract |
Poster
